| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/21/2006 | CA2270887C Methods and compositions for inhibition of angiogenesis |
| 03/21/2006 | CA2133998C Treatment of macular degeneration |
| 03/16/2006 | WO2006028361A1 Implants and microspheres for the sustained release of drugs for ophthalmic use and preparation methods thereof |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2006028269A2 Thiazole derivatives having vap-1 ihibitory activity |
| 03/16/2006 | WO2006028239A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | WO2006028122A1 Agent for preventing and ameliorating obesity |
| 03/16/2006 | US20060058395 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/16/2006 | US20060058345 Use of papaverine-like vasodilator and pharmaceutical composition |
| 03/16/2006 | US20060058329 Pyrazole inhibitors of the transforming growth factor |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058277 Use of oculosurface selective glucocorticoid in the treatment of dry eye |
| 03/16/2006 | US20060058253 Methods to reprogram splice site selection in pre-messenger rnas |
| 03/16/2006 | US20060057668 Antimicrobial polypeptide and utilization thereof |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | CA2579889A1 Thiazole derivatives having vap-1 inhibitory activity |
| 03/16/2006 | CA2579204A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | CA2578958A1 Acetylated starch or starch succinate for treatment of obesity or diabetes |
| 03/15/2006 | EP1634600A1 Antiallergic composition |
| 03/15/2006 | EP1634597A1 Compositions comprising dextromethorphan and quinidine or quinine for the treatment of emotional lability |
| 03/15/2006 | EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators |
| 03/15/2006 | EP1492797B1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 03/15/2006 | EP1444206B1 Substituted benzo[b]azepin-2-one compounds as analgesics |
| 03/15/2006 | EP1401435B1 Topical application of thiazolyl amides |
| 03/15/2006 | EP1372648B1 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 03/15/2006 | EP1339414A4 L-histidine in ophthalmic solutions |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1318819A4 Treatment of trauma, and other indications |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1063885B1 Xylitol compositions for treating upper respiratory conditions |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | CN1747950A 2-(1h-indazole-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| 03/15/2006 | CN1747744A Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 03/15/2006 | CN1746164A Protein antagonist with water channel |
| 03/15/2006 | CN1745850A Implant agent for treating ophthalmopathy |
| 03/15/2006 | CN1745841A Zijing kidney reinforcing pill |
| 03/15/2006 | CN1745836A Zijing liver tonifying pill |
| 03/15/2006 | CN1745830A Preparation of Zijing paste for eye vision recovery |
| 03/15/2006 | CN1745829A Zijing stomach tonifying pill |
| 03/15/2006 | CN1745828A Zijing liver tonifying soup |
| 03/15/2006 | CN1745805A Zijing pill for reinforcing kidney and soothing liver |
| 03/15/2006 | CN1745796A Ziqing tranquilizing drug |
| 03/15/2006 | CN1745760A Vision-improving compound Chinese medicine |
| 03/15/2006 | CN1745751A Preparation composition for eyes |
| 03/15/2006 | CN1245402C Indole derivatives, their preparation, medicinal compositions containing them and use thereof |
| 03/15/2006 | CN1245391C Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 03/15/2006 | CN1245193C Plant leaven with hot and fragrant smell of propylene sulfide and its preparation and use |
| 03/15/2006 | CN1245187C Medicine for treating eye disease caused by visceral disease |
| 03/15/2006 | CN1245166C Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 03/14/2006 | US7012099 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 03/14/2006 | US7012090 Pyranoindoles for treating glaucoma |
| 03/14/2006 | US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/14/2006 | US7011839 Combination of an antimicrobial, especially a quinolone antibiotic, and silver sulfadiazine |
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2295515C Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof |
| 03/09/2006 | WO2006025276A1 Remedy/preventive for ophthalmic diseases containing nattokinase |
| 03/09/2006 | WO2006024770A2 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 03/09/2006 | WO2006024627A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | WO2006004757A3 Topical formulations for treating allergic diseases |
| 03/09/2006 | US20060052610 Piperidine derivatives and process for their production |
| 03/09/2006 | US20060052594 New corticosteroids |
| 03/09/2006 | US20060052440 Medicinal composition for treating sudden deafness |
| 03/09/2006 | US20060052419 Use of pyridly amides as inhibitors of angiogenesis |
| 03/09/2006 | US20060052415 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052398 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 03/09/2006 | US20060052397 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 03/09/2006 | US20060052367 Remedy for glaucoma comprising rho kinase inhibitor and beta-blocker |
| 03/09/2006 | US20060052340 Ophthalmic solution |
| 03/09/2006 | US20060052336 Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 03/09/2006 | US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 03/09/2006 | US20060051361 Vaccine against Streptococcus pneumoniae |
| 03/09/2006 | US20060051331 Optimization of transgene expression in mammalian cells |
| 03/09/2006 | CA2576839A1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | CA2576827A1 Vegf inhibition |
| 03/09/2006 | CA2576781A1 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 03/09/2006 | CA2554420A1 Topical otic compositions and methods of topical treatment or prevention of otic infections |
| 03/08/2006 | EP1632492A1 Tricyclic compound |
| 03/08/2006 | EP1632259A2 Anti-angiogene compositions and methods of use |
| 03/08/2006 | EP1632238A1 Encapsulated cells adapted for implantation into the aqueous and vitreous humor of the eye |
| 03/08/2006 | EP1631591A2 Connective tissue growth factor antibodies |
| 03/08/2006 | EP1631544A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| 03/08/2006 | EP1631355A1 Piperidinyl prostaglandin e analogs |
| 03/08/2006 | EP1631259A1 Otologic nanotechnology |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1365761B1 Therapeutic combination of amlodipine and benazepril |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same. |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1276722B1 Naphthamidine urokinase inhibitors |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |